Login / Signup

Optimization of the CDC Protocol of Molecular Diagnosis of COVID-19 for Timely Diagnosis.

Chao-Ju ChenLi-Ling HsiehShu-Kai LinChu-Feng WangYi-Hui HuangShang-Yi LinPo-Liang Lu
Published in: Diagnostics (Basel, Switzerland) (2020)
Coronavirus disease 2019 (COVID-19), the current uncontrolled outbreak of infectious disease, has caused significant challenges throughout the world. A reliable rapid diagnostic test for COVID-19 is demanded worldwide. The real-time reverse transcriptase polymerase chain was one of the most quickly established methods in the novel viral pandemic and was considered as the gold standard for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this report, we illustrate our experience of applying a protocol from the Taiwan CDC and achieving assay optimization in the immediate circumstances to meet the urgent medical and public health needs.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • coronavirus disease
  • public health
  • infectious diseases
  • randomized controlled trial
  • healthcare
  • high throughput
  • cell proliferation
  • quantum dots
  • structural basis